Chi B. Vu

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Jill C. Milne, Philip Lambert, Simon Schenk et al. · Nature · 2007 · 1.7K citations · Full text

Diabetes Management, Medicine, Diabetes +9

Quantitative Structure−Activity Relationships among Macrolide Antibacterial Agents:  In Vitro and in Vivo Potency against <i>Pasteurella multocida</i>

James W. McFarland, Cynthia M. Berger, S Froshauer et al. · Journal of Medicinal Chemistry · 1997 · 155 citations

Immunology, Antimicrobial Chemotherapy, Drug Resistance +23

Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with <i>in vivo</i> antiresorptive activity

William C. Shakespeare, Michael G. Yang, Regine S. Bohacek et al. · Proceedings of the National Academy of Sciences · 2000 · 133 citations · Full text

Medicinal Chemistry, Sclerostin, Biochemistry +15

Discovery of Imidazo[1,2- <i>b</i> ]thiazole Derivatives as Novel SIRT1 Activators

Chi B. Vu, Jean E. Bemis, Jeremy S. Disch et al. · Journal of Medicinal Chemistry · 2009 · 117 citations · Full text

Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators

Jean E. Bemis, Chi B. Vu, Roger L. Xie et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 90 citations

Heterocyclic, Medicine, Chemistry +5